Beijing Strong Biotechnologies Inc
SZSE:300406
Beijing Strong Biotechnologies Inc
Cash & Cash Equivalents
Beijing Strong Biotechnologies Inc
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Beijing Strong Biotechnologies Inc
SZSE:300406
|
Cash & Cash Equivalents
¥711.6m
|
CAGR 3-Years
14%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Cash & Cash Equivalents
¥15B
|
CAGR 3-Years
33%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash & Cash Equivalents
¥11.4B
|
CAGR 3-Years
108%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash & Cash Equivalents
¥3.8B
|
CAGR 3-Years
75%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash & Cash Equivalents
¥6.3B
|
CAGR 3-Years
68%
|
CAGR 5-Years
54%
|
CAGR 10-Years
20%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash & Cash Equivalents
¥3.1B
|
CAGR 3-Years
84%
|
CAGR 5-Years
71%
|
CAGR 10-Years
N/A
|
See Also
What is Beijing Strong Biotechnologies Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
711.6m
CNY
Based on the financial report for Mar 31, 2024, Beijing Strong Biotechnologies Inc's Cash & Cash Equivalents amounts to 711.6m CNY.
What is Beijing Strong Biotechnologies Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
6%
Over the last year, the Cash & Cash Equivalents growth was 121%. The average annual Cash & Cash Equivalents growth rates for Beijing Strong Biotechnologies Inc have been 14% over the past three years , 6% over the past five years .